These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32663742)
1. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. Vatansev H; Kadiyoran C; Cumhur Cure M; Cure E Med Hypotheses; 2020 Oct; 143():110091. PubMed ID: 32663742 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736 [TBL] [Abstract][Full Text] [Related]
3. Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model. De Oliveira Andrade F; Yu W; Zhang X; Carney E; Hu R; Clarke R; FitzGerald K; Hilakivi-Clarke L Endocr Relat Cancer; 2019 Mar; 26(3):339-353. PubMed ID: 30640711 [TBL] [Abstract][Full Text] [Related]
4. [Mechanism of acquired antiestrogen resistance and its management in breast cancer]. Iino Y; Maemura M; Morishita Y Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167 [TBL] [Abstract][Full Text] [Related]
5. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Verdecchia P; Cavallini C; Spanevello A; Angeli F Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk. Öztürk AB; Çağlayan B Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945 [No Abstract] [Full Text] [Related]
7. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak. Thompson CK; Lee MK; Baker JL; Attai DJ; DiNome ML Ann Surg; 2020 Aug; 272(2):e96-e97. PubMed ID: 32675509 [No Abstract] [Full Text] [Related]
8. Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic. Spring LM; Specht MC; Jimenez RB; Isakoff SJ; Wang GX; Ly A; Shin JA; Bardia A; Moy B N Engl J Med; 2020 Jul; 383(3):262-272. PubMed ID: 32610007 [No Abstract] [Full Text] [Related]
9. A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer. Bogush EA; Ravcheeva AB; Bogush TA; Zabotina TN; Kadagidze ZG; Davydov MI Dokl Biochem Biophys; 2007; 413():83-7. PubMed ID: 17546960 [No Abstract] [Full Text] [Related]
10. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Vuagnat P; Frelaut M; Ramtohul T; Basse C; Diakite S; Noret A; Bellesoeur A; Servois V; Hequet D; Laas E; Kirova Y; Cabel L; Pierga JY; ; Bozec L; Paoletti X; Cottu P; Bidard FC Breast Cancer Res; 2020 May; 22(1):55. PubMed ID: 32460829 [TBL] [Abstract][Full Text] [Related]
11. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Chen L; Li X; Chen M; Feng Y; Xiong C Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer. Mittal R; Chaudhry N; Pathania S; Mukherjee TK Curr Pharm Biotechnol; 2014; 15(12):1141-57. PubMed ID: 25429654 [TBL] [Abstract][Full Text] [Related]
13. Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently? Bhattacharya P; Abderrahman B; Jordan VC Expert Rev Anticancer Ther; 2017 Apr; 17(4):297-310. PubMed ID: 28281842 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer. Lykkesfeldt AE Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958 [TBL] [Abstract][Full Text] [Related]
15. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer. Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581 [TBL] [Abstract][Full Text] [Related]
16. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. Herman ME; Katzenellenbogen BS J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327 [TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal symptoms revealing COVID-19 in Malian breast cancer patient undergoing chemotherapy]. Sidibe FM; Bathily M; Diarra B; Kone AS; Diabate K; Konate M; Cisse HL; Guindo I; Kone AA; Kone J; Berthe D; Ouattara BZ; Fofana Y; Sidibe A; Akpa AA; Dembele JP; Toure BA; Diakite A; Diarra IM; Kone AC; Soumare MD; Minta D; Dao S; Toloba Y; Diallo DA; Sidibe S Bull Cancer; 2020 Oct; 107(10):1019-1023. PubMed ID: 32972763 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China. Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030 [TBL] [Abstract][Full Text] [Related]
19. [Breast cancer management during the COVID 19 pandemic: The CNGOF takes action]. Mathelin C; Nisand I Gynecol Obstet Fertil Senol; 2020 Jun; 48(6):473-474. PubMed ID: 32320812 [No Abstract] [Full Text] [Related]
20. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Steckelings UM; Sumners C Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]